Sutemi
"Pharmaceutical company Almirall has entered a strategic collaboration with Microsoft to steer innovation and digital transformation in dermatology. The three-year collaboration will leverage generative artificial intelligence (genAI) and advanced analytics to enhance drug discovery and development processes, aiming to bring forward new treatments in medical dermatology." $ALM.MC (Laboratorios Almirall SA) $MSFT (Microsoft) www.pharmaceutical-technology.com/news/almirall-microsoft-dermatological-drug/
Like CommentShare
null
.